Eden Research Past Earnings Performance

Past criteria checks 0/6

Eden Research's earnings have been declining at an average annual rate of -31.4%, while the Chemicals industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 11.5% per year.

Key information

-31.4%

Earnings growth rate

-22.3%

EPS growth rate

Chemicals Industry Growth12.4%
Revenue growth rate11.5%
Return on equity-12.0%
Net Margin-38.7%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Eden Research makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:9T7 Revenue, expenses and earnings (GBP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 244-240
31 Mar 244-430
31 Dec 233-630
30 Sep 233-730
30 Jun 232-730
31 Mar 232-530
31 Dec 222-230
30 Sep 222-230
30 Jun 221-230
31 Mar 221-230
31 Dec 211-330
30 Sep 211-330
30 Jun 212-330
31 Mar 211-330
31 Dec 201-220
30 Sep 202-220
30 Jun 202-230
31 Mar 202-120
31 Dec 192-120
30 Sep 192-120
30 Jun 193020
31 Mar 193020
31 Dec 183020
30 Sep 182-120
30 Jun 182-210
31 Mar 182-110
31 Dec 172-110
30 Sep 172-120
30 Jun 171-120
31 Mar 171-120
31 Dec 160-220
30 Sep 161-210
30 Jun 161-110
31 Mar 161-110
31 Dec 151-110
30 Sep 151-210
30 Jun 150-210
31 Mar 150-310
31 Dec 140-310
30 Sep 140-310
30 Jun 140-210
31 Mar 140-210
31 Dec 130-210

Quality Earnings: 9T7 is currently unprofitable.

Growing Profit Margin: 9T7 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 9T7 is unprofitable, and losses have increased over the past 5 years at a rate of 31.4% per year.

Accelerating Growth: Unable to compare 9T7's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 9T7 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (7.2%).


Return on Equity

High ROE: 9T7 has a negative Return on Equity (-12.03%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 02:31
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Eden Research plc is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Adam McCarterCavendish
Christopher DonnellanCavendish
Christopher DonnellanCavendish Historical (Cenkos Securities)